Dr. Royston earned his Bachelor of Arts (1967) and M.D. (1970) degrees from Johns Hopkins University and completed post-doctoral training in Internal Medicine and Medical Oncology at Stanford University. He was involved in the biotechnology industry in San Diego from its inception in 1978 with the founding of Hybritech, Inc. and with the founding of Idec Pharmaceuticals in 1986 which later merged with Biogen. Dr. Royston was instrumental in the formation, financing, and development of numerous successful public biotechnology companies. He was on the faculty of the medical school and cancer center of the University of California, San Diego from 1977 to 1990 and then went on to serve as Founding President and CEO of the Sidney Kimmel Cancer Center from 1990 through 2000. Dr. Royston was appointed to the National Cancer Advisory Board in 1997 and has also served as Chairman of Ligocyte, on the Board of Directors of HemaQuest Pharmaceuticals, and as Founding Managing Partner of Forward Ventures.
Interviewed by Matthew Shindell, Historian, UCSD
At the time of this interview, Dr. Royston served as Founding President and Chief Executive Officer for the Sidney Kimmel Cancer Center.